Skip to main content
. 2004 May 10;101(20):7705–7710. doi: 10.1073/pnas.0402458101

Table 1. Samples tested under code.

Code Sample Anti-HCV plasma screening Anti-HCV RIBA II Anti-E1* Anti-E2* HCV RNA Virus inactivation IgG, %
1 Control IGIV EIA-2 neg Neg Neg Neg Neg Yes 5
2 HCIGIV EIA-2 pos Pos Pos Pos Neg Yes 5
3 HCIGIV EIA-1 pos Pos Pos Pos Pos No 5
4 HCIGIV EIA-1 pos Pos ND ND Neg Yes 5
5 Human albumin EIA-2 neg N/A N/A N/A Neg Yes (5% prot)
6 Plasma pool EIA-1 pos Pos Pos Pos Pos No 1
7 Plasma pool EIA-2 neg Neg Neg Neg Neg No 1
8 Gammagard EIA-2 neg Neg Neg Neg Neg No 10
9 Gammagard EIA-2 neg Neg Neg Neg Pos No 10
10 Gammagard EIA-2 neg Neg Neg Neg Pos No 10
11 Gammagard EIA-2 neg Neg Neg Neg Pos No 10
12 Gammagard EIA-2 neg Neg Neg Neg Pos No 10
13 Gammagard Unscreened Pos Pos Pos Neg No 10
14 Gammagard Unscreened Pos Pos Pos Neg No 10
15 Gammagard Unscreened Pos ND ND Neg No 10
16 Gammagard Unscreened Pos ND ND Neg No 10
17 IGIV EIA-3 neg ND ND ND Neg Yes 10
18 Gammagard Unscreened Pos ND ND Neg No 10
19 Gammagard Unscreened Pos ND ND Neg No 10

pos, positive; neg, negative; ND, not determined; N/A, not applicable.

*

In-house EIA procedures for anti-E1 and anti-E2 (see Materials and Methods for details)

Assumed value